Because CYP46A1 is a key enzyme of cholesterol balance and an essential neuronal stress response factor, the defect of its gene transcription could lead to severe dysfunction as observed in HD or Sca3 and after in vivo inhibition in different brain regions through shRNAs. This evidence concerns the gene ATXN3 and Huntington disease.